We are a charity and rely on donations

Charity Number: 1117194 (England and Wales)

Registered Company: 06000961

Registered address:
Shift.ms, Platform, New Station Street, LS1 4JB, United Kingdom

London office:
Shift.ms, Somerset House, Strand, West Goods Entrance, London WC2R 1LA, United Kingdom

©2024 Shift.ms

@arknat 

Last reply

arknat

Remyelination therapies

Wondering something like this could happen in the near future to remyelinate spinal cord lesions. Wouldn't that be something to look forward ? https://myelitis.org/upcoming-phase-i-remyelination-trial-using-q-cells-in-transverse-myelitis/
6
@Vixen
@Vixen
 

Hi @arknat, 5is is indeed very exciting and would see like the way forward. I think there are other remyelination trials elsewhere that are further advanced, for example Cambridge and Australia, I believe.....let’s keep hoping :-)

@Stumbler
@Stumbler
 

There's so many encouraging areas of research going on.........